Skip to main content
XRTX logo

XRTX · XORTX Therapeutics Inc.

$2.04 -0.01 (-0.49%) At close · Jul 29
Market Cap
$26.63M
Shares
12.99M

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

Short Volume

Date Short Volume Short Exempt Total Volume Short %
2026-07-29 1,906 0 21,024 9.1%
2026-07-28 1,117 1,100 2,310 48.4%
2026-07-27 179 0 3,653 4.9%
2026-07-24 281 0 33,458 0.8%
2026-07-23 768 0 3,647 21.1%
2026-07-22 171 0 753 22.7%
2026-07-21 1,546 0 2,115 73.1%
2026-07-20 303 0 4,523 6.7%
2026-07-17 720 0 3,917 18.4%
2026-07-16 3,837 0 10,879 35.3%
2026-07-15 12 0 437 2.7%
2026-07-14 5,856 0 15,167 38.6%
2026-07-13 4,366 0 10,004 43.6%
2026-07-10 2,860 0 4,519 63.3%
2026-07-09 2,272 0 4,508 50.4%
2026-07-08 1,450 0 5,410 26.8%
2026-07-07 922 0 10,335 8.9%
2026-07-06 3,095 200 5,970 51.8%
2026-07-02 596 0 2,346 25.4%
2026-07-01 881 500 3,773 23.4%
2026-06-30 740 500 4,065 18.2%
2026-06-29 2,375 0 4,718 50.3%
2026-06-26 3,066 0 10,696 28.7%
2026-06-25 212 0 2,532 8.4%
2026-06-24 227 0 1,476 15.4%
2026-06-23 1,743 127 4,079 42.7%
2026-06-22 32 0 2,376 1.3%
2026-06-18 6,790 0 12,952 52.4%
2026-06-17 3,729 0 15,288 24.4%
2026-06-16 4,813 0 12,950 37.2%
2026-06-15 1,869 0 7,215 25.9%
2026-06-12 1,669 0 5,762 29.0%
2026-06-11 4,207 0 9,868 42.6%
2026-06-10 1,046 0 4,751 22.0%
2026-06-09 1,203 0 9,102 13.2%
2026-06-08 863 0 10,912 7.9%
2026-06-05 561 0 8,888 6.3%
2026-06-04 1,939 0 6,009 32.3%
2026-06-03 1,232 0 7,260 17.0%
2026-06-02 4,258 0 11,761 36.2%
2026-06-01 2,538 0 9,804 25.9%
2026-05-29 1,558 0 8,986 17.3%
2026-05-28 2,353 0 24,314 9.7%
2026-05-27 8,466 0 49,326 17.2%
2026-05-26 10,934 1,366 27,515 39.7%
2026-05-22 308 72 11,387 2.7%
2026-05-21 2,094 0 21,775 9.6%
2026-05-20 3,751 251 5,302 70.7%
2026-05-19 3,494 1,050 9,171 38.1%
2026-05-18 6,334 6 17,342 36.5%
Showing 1–50 of 62 days
Key facts CIK 1729214 CUSIP 98420Q405 13F (30d) 1 filings 1 filers Visit website Investor relations